quin2 has been researched along with alprostadil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, GH; White, JG | 1 |
| Ehrlich, YH; Garfield, MG; Kornecki, E; Lenox, RH; Snider, RM | 1 |
| Beretz, A; Cazenave, JP; Corre, G; Lanza, F; Stierlé, A | 1 |
3 other study(ies) available for quin2 and alprostadil
| Article | Year |
|---|---|
Aspirin, prostaglandin E1 and Quin-2 AM-induced platelet dysfunction: restoration of function by noradrenalin.
Topics: Adult; Alprostadil; Aminoquinolines; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Calcium; Cell Membrane; Humans; Norepinephrine; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Adrenergic, alpha; Yohimbine | 1990 |
Modulation of neuronal signal transduction systems by extracellular ATP.
Topics: Adenosine Triphosphate; Aequorin; Alprostadil; Aminoquinolines; Calcium; Cyclic AMP; Cyclic GMP; Fluorescent Dyes; Glioma; Hybrid Cells; Inositol; Inositol Phosphates; Neuroblastoma; Neurons; Phosphorylation; Potassium; Protein Kinases; Tumor Cells, Cultured | 1988 |
Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Alprostadil; Aminoquinolines; Blood Platelets; Calcium; Cyclic AMP; Cytoplasm; Humans; Isoquinolines; Phthalazines; Platelet Aggregation; Quercetin; Quinazolines; Quinolines; Quinolones; Tetrahydroisoquinolines | 1987 |